Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 21 INDUSTRY 16 NIH 9 NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Sarcoma 1 Other solid neoplasm 1 NET 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Pancreatic Neoplasms 1

Interventions

Oxaliplatin 30 Capecitabine 26 Fluorouracil 20 Irinotecan 19 tislelizumab 18 apatinib 16 Paclitaxel 13 Cisplatin 13 S 1 (combination) 12 Radiotherapy 12 Leucovorin 11 Bevacizumab 11 Laparoscopy 9 Drug Therapy 9 Cetuximab 9 sintilimab 8 Endoscopic Mucosal Resection 8 Radiation 7 Gemcitabine 7 Docetaxel 7 camrelizumab 6 XELOX 6 Surgical Procedures, Operative 6 Propranolol 6 Nivolumab 6 Neoadjuvant Therapy 6 Immune Checkpoint Inhibitors 6 Folfox protocol 6 Levoleucovorin 5 HMPL-013 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × olaparib × Gastrointestinal × Clear all

NCT02511223 2023-04-19

10

Sheba Medical Center

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡